Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Clin Nutr. 2022 Feb 3;41(3):731–736. doi: 10.1016/j.clnu.2022.01.019

Table 2.

Associations of fish oil use with risk of dementia.

Non-users Fish oil-users

All-cause dementia P-value
 Cases, N (%) 3,654 (1.2) 2,141 (0.6)
 Model 1 a 1(reference) 0.90 (0.85–0.96) 0.001
 Model 1+ APOE ε4 dosage b 1(reference) 0.91 (0.86–0.96) 0.001
 Model 1+ PRS (without APOE) b 1(reference) 0.90 (0.85–0.96) 0.001

Alzheimer's disease Non-users Fish oil-users P-value

 Cases, N (%) 1,413 (0.5) 969 (0.7)
 Model 1 a 1(reference) 0.99(0.91–1.09) 0.901
 Model 1+ APOE ε4 dosage b 1(reference) 1.00 (0.92–1.10) 0.983
 Model 1+ PRS (without APOE)b 1(reference) 1.00 (0.91–1.09) 0.948

Vascular dementia Non-users Fish oil-users P-value

 Cases, N (%) 834 (0.3) 432 (0.3)
 Model 1 a 1(reference) 0.85 (0.75–0.97) 0.013
 Model 1+ APOE ε4 dosage b 1(reference) 0.85 (0.75–0.97) 0.016
a

Model 1: Cox proportional hazards regression adjusted for age, sex, assessment centers, Townsend index, education, BMI, physical activity, healthy diet, smoking, moderate drinking, frequency of depression, social isolation, hearing problems, other supplements use and history of diabetes, history of high cholesterol, history of hypertension and history of cardiovascular disease.

b

Further adjustment for the first 10 genetic principal components and relatedness.